PSTV – plus therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Plus Therapeutics (NASDAQ:PSTV) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $5.00 price target on the stock.
Plus Therapeutics Expands CNSide Assay Platform to State of California [Yahoo! Finance]
Plus Therapeutics Expands CNSide Assay Platform to State of California
Plus Therapeutics Announces Expansion of CNSide Team and Issuance of Inducement Grants
Plus Therapeutics Highlights Three REYOBIQ™ Clinical Data Presentations at 2025 WFNOS/SNO Annual Meeting
Form 8-K PLUS THERAPEUTICS, INC. For: Nov 17
Form 4 PLUS THERAPEUTICS, INC. For: Nov 04 Filed by: Sims Andrew John Hugh MacIntyre
Form 10-Q PLUS THERAPEUTICS, INC. For: Sep 30
Form 8-K PLUS THERAPEUTICS, INC. For: Oct 30
Form 8-K PLUS THERAPEUTICS, INC. For: Oct 16
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.